inaccurate account of the General Medical Council's policy development on revalidation, ignoring an iterative process with interested parties since 1998 in an attempt to introduce the most fundamental change to medical regulation since its foundation in 1858.
1 2 The GMC clearly has had regard to the legitimate interests of three principal groups-government and the NHS, patients and the public, and the various tribes that make up the UK medical profession.
Despite suggestions to the contrary, an initial exploratory meeting on revalidation convened by Sir Donald Irvine in June 1998 was held in the context of a high profile professional conduct case, but well before the Bristol inquiry report and absolutely nothing to do with Rodney Ledward or, indeed, Harold Shipman. It was recognised then that some doctors were not keeping fully up to date nor were they indulging in reflective practice. Irvine correctly proposed that there was a need to make registration with the GMC more meaningful to the public than a mere recognition that doctors had reached a certain standard of professional knowledge in their early 20s.
Both articles promote the idea that the doctors' regulator should be filling the vacuum within the NHS created by its failing to fulfil its public responsibility to monitor doctors' clinical standards. Clinical governance is now, slowly, being developed and eventually will extend from systems and teams to individuals-but is it reasonable, as both authors postulate, that such monitoring should become the financial and moral responsibility of the GMC sitting in London and Manchester rather than local managers at the coalface?
Although revalidation is a continuing process, it becomes summative only every five years. The NHS and its local systems must not be allowed to abrogate their responsibility for the safety of patients on a day to day basis. Nor should they demand that the GMC and its prime function of assuring fitness to practise and the meaning of the medical register be inappropriately promoted as the first line of defence for the maintenance of clinical quality and safety.
Revalidation, discretionary points, clinical excellence awards-steps on the same ladder
Editor-With reference to the article by Esmail, 1 the purpose of revalidation is to ensure that doctors provide safe, effective health care for patients. The quality of health care that the patient receives could therefore be the basis of revalidation, rather than a measure of the skills and knowledge of the doctor.
Clinical governance could be adapted for purposes of revalidation as the means by which a doctor is held responsible and assessed to ensure the provision of a high quality of health care and the maintenance of the means to achieve it. Revalidation could be granted for fulfilling the requirements of clinical governance.
The advisory committee on clinical excellence awards administers a tried and tested scheme for granting clinical excellence awards, and the trusts have committees responsible for the granting of discretionary points in an integrated scheme. Revalidation could be incorporated in this scheme avoiding a plethora of committees. Involvement of the advisory committee would inspire public confidence.
Revalidation and granting of awards could be a combined exercise. Criteria should be established for revalidation as for the awards. Revalidation may not be required in the first few years after appointment. This strategy could dramatically reduce the cost of the scheme.
Submission of evidence is best simplified as for the awards. Preparation of a folder of evidence would be more appropriate for appraisals.
Similar schemes could be envisaged for general practitioners, involving the primary care trusts.
Professor David Hatch in giving evidence to the Shipman inquiry made an illuminating contribution about revalidation, saying that nobody had given him the opportunity to demonstrate his fitness to practise.
2 Every effort should be made to present revalidation as a process that benefits the doctor as well providing protection for the patient. 
GMC prepares to deliver notable improvements
Editor-Esmail is looking at things from the wrong end of the telescope when claiming that the General Medical Council has failed to grasp the issue of scrutinising doctors' performance. 1 Surely the main lesson that has emerged from the various recent inquiries is that employers of doctors (including primary care trusts) need to ensure that they have in place local systems that can deal quickly, effectively, and fairly with poor or dangerous practice.
That approach has-rightly-underpinned the government's quality agenda since 1997, and it was reaffirmed by Lord Warner at the conference of the Council for Healthcare Regulatory Excellence in March this year, when he said that the responsibilities of employers must be properly exploited before we load more on to regulators. We need proper clarity on the respective roles of each. What is needed is a proper understanding of the role of clinical governance in improving the quality of care and protecting patients from harm, and of the relation between clinical governance and GMC procedures, including revalidation. How curious, then, that Esmail does not even mention clinical governance once. By contrast, Dame Janet Smith devoted an entire chapter of the fifth report to it. The GMC is determined to look forwards, rather than backwards. As our contribution to Sir Liam Donaldson's review, established after the fifth report, we
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Letters have set out a vision for the development of medical regulation over the next few years, which includes creating a robust system for revalidating doctors' licences to practise. As the regulator we want local systems to be subject to robust quality assurance so that evidence such as patient surveys, complaints records, professional development, clinical audits, and prescribing records provide the basis for confirming that doctors are up to date and fit to continue practising. We are certainly not "burying our head in the sand" but preparing to deliver the most significant improvements in professional regulation for 150 years. 
Amanda Watson director of licensing and revalidation

Regulation, regulation, regulation
Editor-Although impressed by the intellectual rigour Dame Janet Smith brought to her inquiry, 1 I am left with some questions after reading the article by Esmail.
2 Did she consider recommending the system her own profession uses to revalidate solicitors, barristers, and judges. And, if she did, why did she reject it?
I hope she would agree that both professions merit a similar standard of regulation. My own experience implies that incompetent doctors are responsible for no greater levels of morbidity, or even of premature mortality, than incompetent lawyers.
Dame Janet is also reported to have urged the General Medical Council to assume the power to expel "unsuitable" medical students, proposing "a test of ethics as a useful and sensible means of weeding out and failing students who had not managed to absorb essential ethical principles that they would be expected to practise throughout their career." 3 If the government does decide to enshrine that wholesome advice in legislation I hope it will impose the same regulation on law schools. More importantly I hope it will devise a new "suitability" test for MPs before they enter parliament and a system for their regular revalidation once they get there. You don't need to monitor world affairs too closely to see that an unethical politician can be several hundred thousand times more lethal than a Dr Shipman.
Were the government to embark on such public spirited legislation, it would, of course, need to set up another regulating body to revalidate and "weed out" the revalidators and "weeders out," and a body to revalidate and weed out the revalidators and weeders out, of the revalidators and weeders out, and so on. 
Profession needs to debate regulator's role
Editor-Esmail insinuates that the public has lost confidence in the medical profession. 1 This is not true. The public puts doctors at the top of the professional tree in poll after poll. The elites of medicine have lost their nerve, and that is the problem. Esmail proposes that doctors are afraid of revalidation. We are not. What we, and our patients, do not want is to invest time and money in a harebrained scheme. We are loath to support yet another cottage industry in medical governance.
Esmail asserts that revalidation is better than appraisal. He provides no evidence, only opinion. Appraisal, by definition, is a means of determining a doctor's effectiveness. This requires that activity data be gathered and then analysed. These data are currently available, albeit incompletely, but are not analysed. They can be refined by using logbooks. That is all that is required to identify poor performance.
Esmail claims that 3% of doctors are seriously deficient. Who says? The Bolam case? 2 Standards set by professors who hardly see patients and who preside over college examinations that these same doctors pass? Professional elites may be obsessed with assessment; patients are not. It is time to put a halt to the self flagellation over Bristol and Shipman and concentrate on improving quality. The public has moved on, and so should we.
The profession needs to debate the role of the regulator. A referendum is essential. Do we persist with self regulation, which allows a small, self appointed group to tell us what to do? Or, do we want a Driver and Vehicle Licensing Agency (DVLA)-style regulator, which would leave us alone to get on with caring for the sick? I know what I would vote for. Determining doctors' fitness to practise is an inappropriate job for a regulator. That is the job of those who employ doctors. 
Olusola O A Oni consultant orthopaedic surgeon
Revalidation process would not pass appraisal
Editor-Catto's paper in the series on the GMC and the future of revalidation, although very thoughtful, does not tackle many of the problems with revalidation as it has been discussed hitherto. 1 Catto also fails to understand that Dame Janet Smith's inquiry report is largely irrelevant to revalidation, particularly for doctors who are not general practitioners.
The current appraisal process, on which revalidation seems likely to be based, is clunky, time consuming, bureaucratic, and largely irrelevant to an assessment of whether a doctor is fit to practise.
Firstly, the current process does not contain any mention of 360°appraisal, surely one of the most effective ways of shining a light into the darker corners of a doctor's practice.
Secondly, although audit is no doubt essential, to perform meaningful audit is extraordinarily difficult if the person being audited is not a surgeon. If I see a patient with pneumonia on a post-take ward round and then hand that patient over to my respiratory physician colleague, is the patient's ultimate outcome my responsibility or that of my colleague, or both? Even something as simple as prescribing audit requires a degree of commitment and funding that most NHS trusts would struggle to match at present. Providing evidence that a doctor has attended training courses is all well and good, but it does not prove that the doctor has changed his or her practice on the basis of the training received.
The General Medical Council needs to get a lot smarter in its approach to revalidation if it is to overcome the huge cynicism that exists in the profession and, more importantly, if it is actually going to achieve its aim of satisfying itself, parliament, and the public that doctors on the register are, and remain, fit to practise. 
Underwater birth and neonatal respiratory distress
Case report does not constitute reliable evidence
Editor-We were concerned and dismayed to see the case report by Kassim et al of respiratory distress for a baby born in water being cited as evidence of the risk of underwater birth. 1 2 Respiratory conditions can occur after any birth, and in the absence of discernible antenatal fetal compromise they are not particular to water birth. This account by two neonatologists and a radiologist from a prominent London centre is likely to provoke fear among practitioners and parents.
Having recently reviewed the evidence about immersion in water during labour and birth we concluded that a clear need existed for further evidence about the safety and effectiveness of water birth.
3 This systematic review provided no basis to deny this care option for women with uncomplicated pregnancy.
Unfortunately this case report contributes to unreliable evidence and information women are offered when making decisions and choices for labour and birth. Safety and effectiveness of immersion in water for birth should be evaluated in a well designed randomised controlled trial. Neither opponents nor proponents serve women and babies well by continuing to accumulate anecdotal reports to support their own biases.
Editor-Cluett et al point out that respiratory conditions can occur after any birth and in the absence of discernible antenatal fetal compromise. However, we had emphasised data that excluded other causes of neonatal respiratory distress in our casenamely, the mother was apyrexial, the membranes had been ruptured less than 18 hours at delivery, the infection screen on the infant gave negative results, there was no fetal distress, and the baby was born vaginally and required no resuscitation. Most importantly, our paediatric radiologist (MS) reported the chest radiograph to show widespread changes consistent with aspiration of birthing pool water. It is implicit in her report and is also obvious from the figure we included of the chest radiograph that the chest radiograph did not show pneumonia, transient tachypnoea of the newborn, airleak, or any other cause of respiratory distress other than aspiration of birthing pool water-hence we made the diagnosis.
We disagree with Cluett et al: it is important for practitioners and parents to be aware of the potential risks of water birth. We want mothers to be able to make a fully informed decision regarding place of delivery. 1 If it is a person whose outlying position in the distribution is almost certainly not due to chance, then they have failed. The numbers outside the 95% confidence intervals are as anticipated from the size of the population, and therefore they are simple outliers. They probably have refined the analysis so that those at the extremes are more likely to be aberrant performers, but they have not shown statistically that this is so. To do so, it would be necessary to show that a disproportionate number were outside the expected confidence intervals. This might be done by demonstrating two populations or possibly by recalculating the confidence intervals, using only those between, say, the 20th and 80th centiles and looking for wide outliers (using 0.1% intervals), clusters, and asymmetry outside the new intervals.
Zainab Kassim clinical research fellow in neonatology
This criticism makes the cautions expressed in the article the more valid. Attempting to uncover true bad performance by global audit is necessarily a very nonspecific process. Although most bad performers will be outliers, the converse is not true. This means that the initial investigations of outliers must be chosen carefully and those investigated treated with delicacy in an absolutely confidential process. 
Statistical method may be difficult to apply in clinical practice
Editor-Harley et al make an interesting proposal for retrospectively detecting outliers. 1 However, we think that, as presented, the method may be quite difficult for clinical audit teams to understand and apply in routine practice.
It might be helpful to think in terms of test statistics. For each consultant in each year, the authors used the Mahalanobis distance to help calculate a kind of test statistic, and they compared this with a reference distribution. From table 2 of their paper (see bmj.com), some 16% of the consultants were flagged as outliers each year. If the most unusual 16% of consultants are flagged each year, then we would expect 3% of consultants to be flagged in three or more of five years simply by chance (simple binomial model). In practice, the authors found that 11 of about 100 consultants were flagged as outliers in three or more years, including Ledward.
We also detected a basic error in the method in the second paragraph of the methods subsection ("Stage 2"). Harley et al used as a cutoff point the mean of the square root of 2 , which is given by the √7 degrees of freedom, which in their study is stated as √7 = 2.66. However, the expectation (mean) of √x is not generally the same as the square root of the mean of x. A distribution with 7 degrees of freedom actually has mean 2.55 (52nd percentile), not 2.66 (58th percentile) as quoted in the paper. This could have made a practical difference to the results.
Authors' reply
Editor-Connolly and Cowling and Hedley raise several technical issues relating to our article. Connolly says that we have not shown that the number of outliers we identified is above that expected by chance alone. When considering the annual analyses, by chance alone one would expect 5% of consultants to be outliers. As table 2 in our paper shows, in any year, we found three times as many outliers as predicted by chance alone.
Cowling and Hedley indicate that our method may be difficult for clinical audit teams to apply routinely. As indicated in our paper, we believe that it is premature to consider routine implementation of our approach without further rigorous prospective testing. Nevertheless, the issue of implementation is important; as we indicate in our discussion, national bodies need to be engaged in this type of work.
Cowling and Hedley also point out there is a 3% chance of an outlier consultant STEPHAN ROUSSEAU/EMPICS appearing as an outlier in three or more years. Although this statement serves as a useful reminder about the role of chance in determining outliers, the underlying assumptions of the binomial model they used-constant probability and independent events-make the usefulness of this calculation unclear. In general, such assumptions apply only really in simple artificial demonstrations and as such are questionable in complex situations such as the one we describe. Furthermore, in our data set not all consultants appear in all five years, thus providing a further basis for questioning the underlying assumptions.
We thank Cowling and Hedley for pointing out that the inclusion of a 1/2 in our computation of the mean of the √ 2 , would provide a better approximation of the mean. So by using ( − 1/2) (where is the degrees of freedom) and not , the mean reduces slightly and the revised number of statistical outliers for table 2 is now 17, 18, 21, 16, and 11 for 1991-2 through to 1995-6, respectively. Ledward is now an outlier in four of the five years analysed.
healthcare professionals involved, preferably in the patient's mother tongue. Most patients are very keen to learn about themselves and their illnesses, irrespective of their literacy.
